JOURNAL OF THE CZECH PHARMACEUTICAL SOCIETY AND THE SLOVAK PHARMACEUTICAL SOCIETY

Čes. slov. farm. 2009, 58(4):172-178

Studies of the properties of tablets from directly compressible isomalt

J. Mužíková*, V. Pavlasová
Charles University in Prague, Faculty of Pharmacy in Hradec Králové, Department of Pharmaceutical Technology, Czech Republic

The paper deals with the study of the properties of tablets from two types of directly compressible isomalt - namely galenIQTM 720 and galenIQTM 721. The study focuses on the dependence of tensile strength and disintegration time of the tablets, on both the compression force, the addition of lubricants, namely magnesium stearate and sodium stearyl fumarate (Pruv) with the concentrations of 0.5% and 1%, and a 50% addition of model active ingredients, namely ascorbic acid and acetylsalicylic acid. The used compression forces were 6, 8 and 10 kN, tablets containing drugs were compressed only with the force of 10 kN. The tensile strength of tablets from both substances increased with increasing compression force, the presence of lubricants did not result in any decrease in strength. The disintegration time of tablets was longer with the use of substance galenIQTM 720, it was prolonged by lubricants and increased with increasing compression force for both substances. The presence of drugs decreased tensile strength, and the tablets containing acetylsalicylic acid showed higher tensile strength. For both drugs, differences within the type of isomalt or lubricants were not significant. The disintegration time of tablets was shorter when ascorbic acid was used; it was the shortest in the case of galenIQTM 721 with Pruv, but in the case of acetylsalicylic acid the disintegration time was the shortest with galenIQTM 721 with magnesium stearate.

Keywords: directly compressible isomalt; lubricants; tensile strength of tablets; disintegration time of tablets
Grants and funding:

The study was supported by the grant MSM 0021620822 and by the firm PALATINIT GmbH Germany, which supplied the samples of the dry binders tested.

Received: July 22, 2009; Accepted: August 17, 2009; Published: April 1, 2009  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Mužíková J, Pavlasová V. Studies of the properties of tablets from directly compressible isomalt. Čes. slov. farm. 2009;58(4):172-178.
Download citation

References

  1. Bolhuis, G. K., Armstrong, N. A.: Pharm. Dev. Technol., 2006; 11, 111-124. Go to original source... Go to PubMed...
  2. PALATINIT GmbH: galenIQTM - The smart excipient, Fir. Lit., 2007, Web: htpp://www.beneo-palatinit.com [1.11.2007].
  3. Ndindayino, F., Henrist, D., Kiekens, F., Van den Mooter, G., Vervaet, C., Remon, J. P.: Int. J. Pharm., 2002; 235, 1-2, 149-157. Go to original source... Go to PubMed...
  4. Fell, J. T., Newton, J. M.: J. Pharm. Sci., 1970; 59, 5, 688-691. Go to original source... Go to PubMed...
  5. Bos, C. E., H. Bolhuis, H., Van Doorne, Lerk, C. F.: Pharm. Weekbl., 1987; Sci. Ed. 9, 274-282. Go to original source... Go to PubMed...
  6. Belousov, V. A.: Khim. Farm. Zh., 1976; 10, 105-111. Go to original source...
  7. Luhn, O.: Manuf. Chem., 2006; June: 36-38. Go to original source...
  8. Bolhuis, G. K., Chowhan, Z. T.: Materials for direct compaction. In: Alderborn, G, Nystrőm, Ch. eds. Pharmaceutical Powder Compaction Technology. Inc.: New York: Marcel Dekker 1996; 486-500. Go to original source...




Czech and Slovak Pharmacy

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.